mounjaro retatrutide vs (UK): the simple, evidence‑based guide Retatrutide vs Mounjaro: Which Weight

Adverse Effects Profile (Phase 2 Data) The Phase 2 NEJM 2023 trial reported the following adverse event profile

GLP-1s support weight loss by: Delaying gastric emptying, which helps you feel fuller for longer after meals Regulating blood sugar, which can support steady energy and fewer cravings Reducing appetite and food noise by acting on hunger-regulating areas of the brain While Ozempic, Wegovy, Foundayo, and Zepbound all fall under the GLP-1 umbrella, Zepbound is unique in that it also targets another hormone called GIP (glucose-dependent insulinotropic polypeptide)

Experientially, its exhausting

Gently swirl/roll until dissolved (do not shake)

You can also discuss alternative treatment options with your healthcare provider to find an approach that works best for you